Literature DB >> 9515730

Diadenosine 5',5"-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart.

A Jovanovic1, S Jovanovic, D C Mays, J J Lipsky, A Terzic.   

Abstract

Dinucleotide polyphosphates (ApnA) have emerged as signaling molecules in rapidly dividing cells. The presence and role of Ap5A in the heart remain unknown. Here, we report that the myocardium contains abundant amounts of diadenosine 5',5"-P1,P5-pentaphosphate (Ap5A), a member of the ApnA family. Ischemia induced 10-fold decrease in the myocardial concentration of Ap5A. A target of Ap5A action was identified to be the cardiac ATP-sensitive K+ (K(ATP)) channel, a metabolism-sensitive ion conductance activated in ischemia. At levels found in hearts prior to ischemia, Ap5A maintained a low probability of K(ATP) channel opening, but at levels found in hearts following ischemia, Ap5A allowed a high probability of K(ATP) channel opening. Taken together, the present data suggest that Ap5A harbors the properties of a signaling molecule involved in the cardiac response to metabolic stress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515730     DOI: 10.1016/s0014-5793(98)00114-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels.

Authors:  A J Carrasco; P P Dzeja; A E Alekseev; D Pucar; L V Zingman; M R Abraham; D Hodgson; M Bienengraeber; M Puceat; E Janssen; B Wieringa; A Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 2.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Endogenous coenzyme A glutathione disulfide in human myocardial tissue.

Authors:  J Luo; V Jankowski; L Henning; H Schlüter; W Zidek; J Jankowski
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

4.  Diadenosine tetra- and pentaphosphates affect contractility and bioelectrical activity in the rat heart via P2 purinergic receptors.

Authors:  Ksenia B Pustovit; Vladislav S Kuzmin; Denis V Abramochkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-17       Impact factor: 3.000

5.  Changes in extracellular pH and myocardial ischaemia alter the cardiac effects of diadenosine tetraphosphate and pentaphosphate.

Authors:  B M Stavrou; C Beck; N A Flores
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Molecular determinants of KATP channel inhibition by ATP.

Authors:  S J Tucker; F M Gribble; P Proks; S Trapp; T J Ryder; T Haug; F Reimann; F M Ashcroft
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

7.  Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.

Authors:  B Brandts; R Borchard; D Dirkmann; I Wickenbrock; B Sievers; M van Bracht; M W Prull; H-J Trappe
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

8.  Nucleoside Tetra- and Pentaphosphates Prepared Using a Tetraphosphorylation Reagent Are Potent Inhibitors of Ribonuclease A.

Authors:  Scott M Shepard; Ian W Windsor; Ronald T Raines; Christopher C Cummins
Journal:  J Am Chem Soc       Date:  2019-11-11       Impact factor: 15.419

9.  Cloning and characterisation of hAps1 and hAps2, human diadenosine polyphosphate-metabolising Nudix hydrolases.

Authors:  Nick R Leslie; Alexander G McLennan; Stephen T Safrany
Journal:  BMC Biochem       Date:  2002-07-16       Impact factor: 4.059

10.  Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

Authors:  Eugenia Trushina; Tumpa Dutta; Xuan-Mai T Persson; Michelle M Mielke; Ronald C Petersen
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.